Centene Corporation raised its full-year 2026 adjusted earnings forecast to over $5.20 per share on Tuesday, driven by stronger-than-expected Medicare performance and improved cost controls. The health insurer also reported third-quarter revenues of $50.65 billion and signaled that its Medicare Advantage business is reaching break-even a full year ahead of schedule.
Third-quarter results for Centene delivered a rare combination on Wall Street: a financial beat that prompted management to raise full-year guidance for the second time this year. The company posted adjusted diluted earnings per share of 58 cents for the quarter ended September 30, 2026, alongside premium and service revenues totaling $45.1 billion. Total consolidated revenues reached $50.65 billion, marking a 1.9% increase from the same period a year earlier. While the company recorded a GAAP net loss attributable to Centene of $71 million—equating to a diluted loss of 14 cents per share—that figure reflected $276 million in severance costs tied to enterprise optimization and contract exits, alongside $35 million in vendor expenses.
Chief Executive Officer Sarah London pointed to steady underlying fundamentals across core operations as the driver behind a faster recovery than previously anticipated. We are excited to carry the positive momentum we are producing across our businesses into 2027,
London told analysts during the Q3 earnings call.
Medicare Advantage Reaches Break-Even Early While Marketplace Bounces Back
The centerpiece of Centene’s quarterly outperformance was its Medicare segment, which helped hold the consolidated health benefits ratio at 92.7%. Premium and service revenue within Medicare advanced 19.9% year-over-year to reach $11.3 billion, propelled by lower-than-planned medical trends as internal cost-management initiatives took hold. Company executives highlighted that Medicare Advantage is on track to achieve break-even throughout 2026, marking a full year of acceleration from its original multi-year recovery plan.
![[Centene Q3 2026 Earnings Call] Centene Raises 2026 EPS Outlook to Over $5.20 as Medicare Break-Even Arrives a Year Early](https://img.biggo.com/RlxUt_0dHu00L-QYex1xlfbk1lzqv_xVqy6fEX7cMo8/fit/1200/0/sm/0/aHR0cHM6Ly9pbWcuYmdvLm9uZS9uZXdzLWltYWdlL2Vhcm5pbmdzX2NhcmQvMjAyNi0xMC9VU19DTkNfMjAyNi0xMC0yN18xNzkzMTE0MzQ3LndlYnA.jpg "Photo: finance.biggo.com")
We are pleased to be forecasting to reach Medicare Advantage breakeven in 2026, a year earlier than our multi-year plan.
Drew Asher, Chief Financial Officer, Centene Corporation
Commercial operations, anchored by the Ambetter Marketplace business, continued what Chief Financial Officer Drew Asher described as a marvelous turnaround
from 2025. Medicaid and Marketplace are on track, according to Centene’s third-quarter financial results.
Medicaid Trends Stabilize Ahead of Nationwide Work Requirements
Medicaid revenue rose 4% during the quarter to reach $24.1 billion, supported by state-level rate hikes and improved pricing structures. The Medicaid health benefits ratio settled at 93.6%, reflecting a 30-basis-point sequential improvement that keeps the company on target for its full-year projection of approximately 93.5%. Core medical trends remained stable, bolstered by consecutive quarters of year-over-year improvement in behavioral health and early signs of similar stabilization in home healthcare.
Medicaid operations will change nationwide as work requirements are implemented. Total company membership closed the quarter at 25.7 million, down 8.1% from the previous year due to ongoing eligibility reviews.
Balance Sheet Actions and Upgraded 2026 Guidance Metrics
Bolstered by its operational progress, Centene lifted its full-year financial targets across multiple categories. The company raised its GAAP diluted earnings guidance to greater than $3.46 per share and elevated its adjusted diluted EPS floor to greater than $5.20. Full-year revenue expectations were likewise revised upward to a range of $196.5 billion to $200.5 billion.
| Financial Metric | Third-Quarter 2026 Result | Full-Year Guidance Update |
|---|---|---|
| Adjusted Diluted EPS | $0.58 | Greater than $5.20 |
| GAAP Diluted EPS (Loss) | $(0.14) | Greater than $3.46 |
| Consolidated Revenues | $50.65 billion | $196.5 billion to $200.5 billion |
| Health Benefits Ratio | 92.7% | Full-year midpoint improved to 90.75% |
Parallel to its earnings upgrades, Centene actively trimmed its financial obligations. The enterprise reduced its total debt by $1.1 billion since June 30, 2026, a figure that includes the complete redemption of its 2027 Senior Notes during October.
Analysts Project Earnings Expansion for Centene into 2027
Looking beyond the current fiscal year, executive leadership expressed confidence that earnings expansion will persist into 2027 from both the updated baseline and the newly raised 2026 forecast. Wall Street analysts tracking the stock currently project a profit of $5.34 per share for 2027, according to data compiled by LSEG. Morningstar analyst Julie Utterback noted that investors may appreciate the positive expected growth trajectory, despite ongoing policy uncertainties surrounding the Medicaid market.
Shares of Centene responded positively to the earnings release and conference call, rising roughly 3% in trading as the market digested the combination of cost containment, upwardly revised profit floors, and an accelerated timeline for Medicare profitability.